Though there is limited evidence, outcomes appear to be relatively poor with a review of outcome studies finding that two thirds of people with<unk>  continue to experience episodes and more than half are dependent on the Social Security program at three-year follow-up. This outcome data was obtained in a referral-based academic epilepsy center and loss to follow-up was considerable; the authors point out ways in which this may have biased their outcome data. Outcome was shown to be better in people with higher IQ, social status, greater educational attainments, younger age of onset and diagnosis, attacks with less dramatic features, and fewer additional somatoform complaints. For individuals who pursue treatment for<unk> , CBT has shown varying rates of success but it has been established as one of the most promising treatments to date. ReACT has shown reduction in symptoms by 100% seven days after treatment and 82% of individuals who completed the therapy remained symptom free for 60 days. A follow-up has not been done to see if the therapy retained its reduction of symptoms beyond the 60 days. The largest trial of CBT for<unk>  though found no significant reduction in monthly seizures compared to the control arm at 12 months, however there were significant improvements on a number of secondary outcomes, such as psychosocial functioning, and self-rated and clinician-rated global change.
Psychogenic non-epileptic seizure
Status epilepticus
Post-traumatic seizure
Seizure
Musicogenic seizure
Non-epileptic seizure
Reflex seizure
Febrile seizure